相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunotherapy with immune checkpoint inhibitors in colorectal cancer: what is the future beyond deficient mismatch-repair tumours?
Nicolas Huyghe et al.
GASTROENTEROLOGY REPORT (2020)
Global Burden of 5 Major Types of Gastrointestinal Cancer
Melina Arnold et al.
GASTROENTEROLOGY (2020)
Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5-FU
Jing Sang et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression
Chenglai Xia et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells
Baojie Zhang et al.
CANCERS (2019)
Metformin induces TPC-1 cell apoptosis through endoplasmic reticulum stress-associated pathways in vitro and in vivo
Jianwen Ye et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models
Devalingam Mahalingam et al.
CANCERS (2019)
Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer
Sorbarikor Piawah et al.
CANCER (2019)
Preventative delivery of IL-35 by Lactococcus lactis ameliorates DSS-induced colitis in mice
Jianyong Wang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)
Death receptor 5 is activated by fucosylation in colon cancer cells
Baojie Zhang et al.
FEBS JOURNAL (2019)
Role of Oral Microbiota in Cancer Development
Tomasz M. Karpinski
MICROORGANISMS (2019)
Artonin E sensitizes TRAIL-induced apoptosis by DR5 upregulation and cFLIP downregulation in TRAIL-refractory colorectal cancer LoVo cells
Thanet Sophonnithiprasert et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
In vitro characterization of spheres derived from colorectal cancer cell lines
Agata Olejniczak et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Effects of physical activity on colorectal cancer risk among family history and body mass index subgroups: a systematic review and meta-analysis
Eileen Shaw et al.
BMC CANCER (2018)
Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells
Liam Chung et al.
CELL HOST & MICROBE (2018)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2018)
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
Jong-Ho Cha et al.
MOLECULAR CELL (2018)
Drug resistance and new therapies in colorectal cancer
Kevin Van der Jeught et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Secretion of tumoricidal human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by recombinant Lactococcus lactis: optimization of in vitro synthesis conditions
Katarzyna Ciacma et al.
MICROBIAL CELL FACTORIES (2018)
Metformin and Colorectal Cancer
Takuma Higurashi et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
Nicole E. Scharping et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Dextran sulphate sodium colitis in C57BL/6J mice is alleviated by Lactococcus lactis and worsened by the neutralization of Tumor necrosis Factor α
Aies Berlec et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Cancer-associated fecal microbial markers in colorectal cancer detection
Vincy Eklof et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Molecular Basis of Alcohol-Related Gastric and Colon Cancer
Hye-Kyung Na et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Secretion of biologically active pancreatitis-associated protein I ( PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis
Rodrigo D. Carvalho et al.
MICROBIAL CELL FACTORIES (2017)
Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
Fanqiang Meng et al.
JOURNAL OF DIABETES RESEARCH (2017)
Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production
Angela Mogavero et al.
SCIENTIFIC REPORTS (2017)
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Kosuke Mima et al.
GUT (2016)
Recombinant Lactococcus lactis expressing porcine insulin-like growth factor I ameliorates DSS-induced colitis in mice
Shujie Liu et al.
BMC BIOTECHNOLOGY (2016)
Onto better TRAILs for cancer treatment
D. de Miguel et al.
CELL DEATH AND DIFFERENTIATION (2016)
Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?
Navdeep S. Chandel et al.
CELL METABOLISM (2016)
Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy
Ryan J. O. Dowling et al.
CELL METABOLISM (2016)
From mice to men: Murine models of colorectal cancer for use in translational research
Jonathan P. Evans et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Effect of probiotics on small intestinal bacterial overgrowth in patients with gastric and colorectal cancer
Sufang Liang et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2016)
Anticancer and Anti-Inflammatory Activity of Probiotic Lactococcus lactis NK34
Kyoung Jun Han et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2015)
Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancer
J. Yang et al.
ONCOGENESIS (2015)
Spherical Cancer Models in Tumor Biology
Louis-Bastien Weiswald et al.
NEOPLASIA (2015)
Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice
Suguru Shigemori et al.
MICROBIAL CELL FACTORIES (2015)
Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci
Luis G. Bermudez-Humaran et al.
MICROBIAL CELL FACTORIES (2015)
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Kivanc Birsoy et al.
NATURE (2014)
TRAIL-Mediated Apoptosis in Breast Cancer Cells Cultured as 3D Spheroids
Siddarth Chandrasekaran et al.
PLOS ONE (2014)
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
William W. Wheaton et al.
ELIFE (2014)
In Vitro Comparison of the Effects of Probiotic, Commensal and Pathogenic Strains on Macrophage Polarization
Trine Eker Christoffersen et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2014)
Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL
Bodvael Pennarun et al.
JOURNAL OF PATHOLOGY (2013)
Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
Stephen Yiu Chuen Choi et al.
JOURNAL OF PATHOLOGY (2013)
Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways
M. van Dijk et al.
CELL DEATH & DISEASE (2013)
Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing
H. Voersmann et al.
CELL DEATH & DISEASE (2013)
Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model
Jianxiang Chen et al.
CANCER SCIENCE (2012)
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers
Tingting Wang et al.
ISME JOURNAL (2012)
The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo
Kiyohito Kato et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
Meei-Shyuan Lee et al.
BMC CANCER (2011)
Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
Dimitrios Iliopoulos et al.
CANCER RESEARCH (2011)
Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes A meta-analysis
Zhi-Jiang Zhang et al.
DIABETES CARE (2011)
Oxaliplatin Sensitizes Human Colon Cancer Cells to TRAIL Through JNK-Dependent Phosphorylation of Bcl-xL
Zineb El Fajoui et al.
GASTROENTEROLOGY (2011)
Epigenetics and colorectal cancer
Victoria Valinluck Lao et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Tumor-targeted delivery of biologically active TRAIL protein
H-Y Zhang et al.
CANCER GENE THERAPY (2010)
Hereditary and Familial Colon Cancer
Kory W. Jasperson et al.
GASTROENTEROLOGY (2010)
Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05
Valerie Boige et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Attenuated Salmonella typhimurium carrying TRAIL and VP3 genes inhibits the growth of gastric cancer cells in vitro and in vivo
Hong-Dan Cao et al.
TUMORI JOURNAL (2010)
Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism
Shinichi Ota et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice
S. Ganai et al.
BRITISH JOURNAL OF CANCER (2009)
Diet and epigenetics in colon cancer
Minna Nystrom et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Containment of tumor-colonizing bacteria by host neutrophils
Kathrin Westphal et al.
CANCER RESEARCH (2008)
Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice
Alejandra de Moreno de LeBlanc et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Synergism of CPT-11 and Apo2L/TRAIL against two differentially sensitive human colon tumor xenografts
Kenji Sugamura et al.
ONCOLOGY (2008)
Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients
Joseph Rafter et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
The promise of TRAIL - potential and risks of a novel anticancer therapy
Ronald Koschny et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity
Gabriel Vinderola et al.
CYTOKINE (2006)
A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease
Henri Braat et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Effect of oral Lactococcus lactis containing endostatin on 1, 2-dimethylhydrazine-induced colon tumor in rats
Wei Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP
L Galligan et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Benefit-risk assessment of irinotecan in advanced colorectal cancer
B Glimelius
DRUG SAFETY (2005)
Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis
ZY Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy
SL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax
H LeBlanc et al.
NATURE MEDICINE (2002)
A meta-analysis of alcohol drinking and cancer risk
V Bagnardi et al.
BRITISH JOURNAL OF CANCER (2001)
Sensitization of human colon cancer cells to TRAIL-mediated apoptosis
A Hernandez et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2001)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
